Correction to: Characterization of immortalized human islet stromal cells reveals a MSC-like profile with pancreatic features.

Journal

Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581

Informations de publication

Date de publication:
21 05 2020
Historique:
entrez: 23 5 2020
pubmed: 23 5 2020
medline: 23 5 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via the original article.

Identifiants

DOI: 10.1186/s13287-020-01717-4 PMID: 32438928 PMC: PMC7240903
pubmed: 32438928
doi: 10.1186/s13287-020-01717-4
pii: 10.1186/s13287-020-01717-4
pmc: PMC7240903
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

190

Commentaires et corrections

Type : ErratumFor
corrected authors name to "De Vos"

Références

Stem Cell Res Ther. 2020 Apr 17;11(1):158
pubmed: 32303252

Auteurs

Orianne Villard (O)

Laboratory of Cell Therapy for Diabetes, Institute of Regenerative Medicine and Biotherapy, Univ. Montpellier, CHU Montpellier, Montpellier, France.
Department of Endocrinology, Diabetes, and Nutrition, Univ. Montpellier, CHU Montpellier, Montpellier, France.

Mathieu Armanet (M)

Laboratory of Cell Therapy for Diabetes, Institute of Regenerative Medicine and Biotherapy, Univ. Montpellier, CHU Montpellier, Montpellier, France.
Cell Therapy Unit, Hospital Saint- Louis, AP-HP, Paris, France.
Department of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital, 8 avenue de la Sallaz -, 1011, Lausanne, Switzerland.

Guilhem Couderc (G)

Department of Biological Haematology, Univ. Montpellier, CHU Montpellier, Montpellier, France.
Department of Cell and Tissue Engineering, Univ. Montpellier, CHU Montpellier, Montpellier, France.

Claire Bony (C)

IRMB, INSERM U 1183, Univ Montpellier, INSERM, Montpellier, France.

Jerome Moreaux (J)

Department of Biological Haematology, Univ. Montpellier, CHU Montpellier, Montpellier, France.
IGH, Univ Montpellier, CNRS, Montpellier, France.

Daniele Noël (D)

IRMB, INSERM U 1183, Univ Montpellier, INSERM, Montpellier, France.

John De Vos (J)

Department of Biological Haematology, Univ. Montpellier, CHU Montpellier, Montpellier, France.
Department of Cell and Tissue Engineering, Univ. Montpellier, CHU Montpellier, Montpellier, France.
IRMB, INSERM U 1183, Univ Montpellier, INSERM, Montpellier, France.

Bernard Klein (B)

Department of Cell and Tissue Engineering, Univ. Montpellier, CHU Montpellier, Montpellier, France.

Jean-Luc Veyrune (JL)

Department of Biological Haematology, Univ. Montpellier, CHU Montpellier, Montpellier, France.
Department of Cell and Tissue Engineering, Univ. Montpellier, CHU Montpellier, Montpellier, France.

Anne Wojtusciszyn (A)

Laboratory of Cell Therapy for Diabetes, Institute of Regenerative Medicine and Biotherapy, Univ. Montpellier, CHU Montpellier, Montpellier, France. Anne.Wojtusciszyn@chuv.ch.
Department of Endocrinology, Diabetes, and Nutrition, Univ. Montpellier, CHU Montpellier, Montpellier, France. Anne.Wojtusciszyn@chuv.ch.
Department of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital, 8 avenue de la Sallaz, 1011, Lausanne, Switzerland. Anne.Wojtusciszyn@chuv.ch.

Classifications MeSH